Correspondence 0001213900-24-053824 from Haoxi Health Technology Ltd (HAO)
Haoxi Health Technology Ltd
Date: June 18, 2024 · CIK: 0001954594 · Accession: 0001213900-24-053824
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280174
Letter
Via EDGAR Division of Corporation Finance Office of Manufacturing Attention: Nicholas Nalbantian Re: Haoxi Health Technology Limited Registration Statement on Form F-1, as amended Initially Filed on June 13, 2024 File No. 333-280174
Dear Mr. Nalbantian:
On June 13, 2024, Haoxi Health Technology Limited (the “Company”) requested acceleration of the effective date of the above referenced Registration Statement so that it would become effective at 4:30 p.m. ET on June 17, 2024, or as soon as thereafter as practicable, which date the Company subsequently requested be extended to 4:30 p.m. ET on June 18, 2024. We hereby withdraw our request for acceleration of effectiveness.
Very truly yours,
Haoxi Health Technology Limited
Show Raw Text
CORRESP
1
filename1.htm
Haoxi Health Technology Limited
June 18, 2024
Via EDGAR
Division of Corporation Finance
Office of Manufacturing
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C., 20549
Attention:
Nicholas Nalbantian
Re:
Haoxi Health Technology Limited
Registration Statement on Form F-1, as amended
Initially Filed on June 13, 2024
File No. 333-280174
Dear Mr. Nalbantian:
On June 13, 2024, Haoxi Health
Technology Limited (the “Company”) requested acceleration of the effective date of the above referenced Registration Statement
so that it would become effective at 4:30 p.m. ET on June 17, 2024, or as soon as thereafter as practicable, which date the Company subsequently
requested be extended to 4:30 p.m. ET on June 18, 2024. We hereby withdraw our request for acceleration of effectiveness.
Very truly yours,
Haoxi Health Technology Limited
By:
/s/ Fan Zhen
Name:
Fan Zhen
Title:
Chief Executive Officer, Director